Future Market Insights has announced the addition of the “Vascular Access Systems Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.

1. sales@futuremarketinsights.com
Vascular Access
Systems Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016-2026
www.futuremarketinsights.comFuture Market Insights

2. Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Subscription Information
 Customized Research
 Syndicated Research
 Investment Research
 Social Media Research
Sector Coverage
 Automotive and Transportation
 Electronics, Semiconductor, and ICT
 Retail and Consumer Products
 Industrial Automation and Equipment
 Chemicals & Materials
 Food and Beverages
 Services and Utilities
 Energy, Mining, Oil, and Gas
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com

3. Vascular access systems are intended for a series of diagnostic tests and treatments such as
central venous pressure readings, blood sampling, fluid infusion, blood transfusion,
parenteral and drugs administration such as chemotherapeutic agents, analgesics,
antibiotics. Vascular access systems can be defined as the material which is implanted
subcutaneously in a region over the upper chest wall, having a dwell time of nearly 14 days,
with the catheters inserted in the sub clavian vein, jugular vein, or basilic vein. Central
Venous Access systems are essential for the care of many sick children. In order to reduce the
risk of infection and thrombosis and also to increase the line longevity, appropriate type of
catheter must be selected and inserted in a standardized procedure. Vascular access systems
market covers implantable-ports, Huber needles, (PICCs) peripherally inserted central
catheters, (CVCs) central venous catheters, dialysis catheters, needleless connectors, needles
and syringes. The usage of these medical systems depends on various medical conditions and
its requirements that may include the purpose for its requirements, size of the device, the
duration of time it needs to be in-situ. Peripheral vascular access systems are the most
appropriate for short term therapies as they cause less irritation. A peripherally inserted
central catheter is inserted through antecubital fossa vein, which may be basilica or cephalic,
further progresses through the superior vena cava. The position of the catheter’s tip is
radiologic ally confirmed. The procedure are relatively easy to insert. This makes them a
potentially more economically option. The risk involved for the rate of thrombosis and sepsis
is lowered. The risk of large vein perforation and pneumothorax is also reduced, which is
linked to centrally inserted catheters. Whereas central vascular access systems are used in
cases like medicines having greater pH than 9.0 or less than 5.0, parenteral nutrition with
glucose concentration greater than 10%, infusion fluids which are known irritants, intra
Report DescriptionReport Description

4. venous inotropes and vesicants. Tunneled central venous catheter are known as Hickman
lines. These are more often required when the patient is on long-term infusion therapy,
example chemotherapy, and total parentral nutrition and also provide access for taking
blood samples. This type of line is manufactured in the form of large-bore silicone line having
single or double lumen. Tunneled lines can be used for long-term infusion therapy with the
time duration ranging from months to years. The tip of the catheter is directly inserted into
the subclavian vein or jugular and then it is threaded through to end up in the superior vena
cava. Various tunneled central venous catheters are equipped with a fibrous cuff. These are
assembled in the skin tunnel. This enables the tissue of the patient to bond with the line so
as to create a secure fix. This mechanical barrier stops infection from reaching the
bloodstream to cause sepsis. These central venous catheters can be of two types, namely
open-ended or valved. This type of line insertion is done usually in theatre or radiology with
the help of an image intensifier for the correct positioning of the catheter. The non-tunneled
type is often known as a short-term percutaneous central venous catheter and is most
commonly used central venous catheter in secondary care. It is directly inserted into a
central vein. Strict sterile conditions are required for the insertion of this type of catheter.
The positioning of non- tunneled catheter is to be confirmed using radiological devices. The
Jugular region (area near to the neck) is more susceptible to infection because of the
difficulty of placing the catheter to the neck of the patient securely. Implantable ports are
vascular access systems inserted into the chest, antecubital area or abdomen. They are
useful in long-term intravenous therapy, blood sampling, bolus injections and total parentral
nutrition. The recent advancement in the vascular access devices such as central venous
catheter and peripheral inserted central catheters have lowered the use of implantable
Report DescriptionReport Description

5. ports. Ports are inserted subcutaneously. Implantable ports are often preferred by the patient
because they are less visible. Medical staff prefer them as they are linked with less risk and are
easily accessed. These ports can remain in situ for up to seven days.
Ports have been used for epidural pain relief and can be used alternatively for subcutaneous
infusions. The condition of being unobstructed is maintained by rinsing heparin solution after
definite intervals. It involves minimal manipulation and care.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-
1737
Vascular Access Systems Market: Drivers and Restraints
As some of the central venous catheter can be in place for months together but replacement is
required for few catheters due to the poor functioning. Certain types of ports have a life of
reservoir septum of about 1000 puncture that is not at all suitable for patients who require
daily IV access. Few patients have poor vein condition which is not at all suitable for placement
of catheter. Long term access of the veins eventually lead to the vein damage (example: long
term IV feeding). These all factors contributes to the restraints of the vascular access market.
Globally, there is a constant rise in number of diseases like as cancer, trauma, and acute illness
which has significantly raised the demand of proficient vascular access systems in recent years
by healthcare professionals in hospitals, emergency rooms, and operation theaters. Further
contributing to the driver for the vascular access system market.
Report DescriptionReport Description

6. Vascular Access Systems Market: Segmentation
• By Product
• Central Vascular Access System
• Central Vascular Catheter
• Non tunneled
• Tunneled
• Implanted Ports
• Peripheral Vascular Access System
• Peripheral Catheter
• Midline Catheter
• By End User
• Hospital Pharmacy
• Ambulatory Surgical Centre
• Hospital Pharmacy
• Catheterization Lab
• By region
• North America
• Latin America
Report DescriptionReport Description

7. • Eastern Europe
• Asia Pacific Excl. Japan
• Japan
• MEA
Vascular Access Systems Market: Overview
Depending on geographic region, global vascular access system market is segmented into
seven key regions: North America, South America, Eastern Europe, Western Europe, Asia
Pacific, Japan, and Middle East & Africa.
North America holds the largest share of the global vascular access systems due to the
cumulative aging population and extensive technological advancement.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1737
Vascular Access Systems Market: Region-wise Outlook
Based on geographic region, global vascular access system market is segmented into seven key
regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding
Japan, Japan, and Middle East & Africa.
North America holds the largest share of the global vascular access systems owing to the
cumulative aging population and extensive technological advancement.
Report DescriptionReport Description

8. Cluster Headache Syndrome Market: Key Players
Nipro Medical Corporation, B. Braun Medical Inc., Edwards Life sciences Corporation,
Medtronic, Siemens Medical Solutions Inc., Baxter, , GE Healthcare Inc., Teleflex Medical and.
Becton, Dickinson and Company.
Report DescriptionReport Description

9. Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705